Birmingham Hospital Opens New Automated Blood Sciences Laboratory
|
By LabMedica International staff writers Posted on 14 Jun 2012 |

Image: The new Queen Elizabeth Hospital Birmingham’s laboratory uses state-of-the-art Roche analytical platforms to reduce turnaround times (Photo courtesy of the University Hospitals Birmingham NHS Foundation Trust).
A new automated blood sciences laboratory in a Birmingham hospital has an automated track system that simplifies laboratory processes and improves turnaround times.
The University Hospitals Birmingham NHS Foundation Trust has opened an automated blood sciences laboratory at the new Queen Elizabeth Hospital in Birmingham (Birmingham, United Kingdom). Equipped with state-of-the-art Roche (Burgess Hill, United Kingdom) analytical platforms and track system, the new laboratory ensures a very efficient workflow and will reduce turnaround times (TAT) for routine, high throughput work.
The track system consists of two cobas 8000 platforms (one with two cobas c 701 chemistry modules and two cobas e 602 immunoassay modules and the other with one cobas c 701 and two cobas e 602 modules), a modular preanalytics module and a cobas p 501/701 post-analytical unit for automated sample storage and retrieval.
The cobas 8000 modular analyzer series is designed for high workload laboratories and can cover a range of 3 up to 15 million tests per year. With a peak throughput of 8,400 tests per hour and many innovative design elements to allow unrestricted sample flow and intelligent sample routing, the cobas 8000 modular analyzer series significantly improves sample turnaround time and efficiently addresses peak demands. High speed, intelligent sample dynamics, and workflow improvements further enhance productivity and efficiency for high workload laboratories.
“The fully automated track system with pre- and post-analytics has eliminated the need for manual transfer and storage of samples once they are loaded on the system”, explained laboratory manager, Chris Gaskin. “The cobas 8000 platforms are designed for high throughput and the whole Roche solution has helped us to be more lean in our processes and is much more TAT efficient for our high workloads.”
The laboratory also has a standalone cobas p 512 module for automated sample receipt. “In the next few months, we aim to introduce a pneumatic sample delivery system and ward order communications throughout the hospital,” Chris Gaskin concluded. “When a test is requested on the ward, a barcode label will be printed automatically. Then, when samples arrive in the laboratory, they will be loaded directly onto the cobas p 512. The system will register receipt on Laboratory Information Management System (LIMS) and then sort the samples into appropriate racks, depending on their destination. This will eliminate the need for paperwork, allowing the process to be entirely electronic from request to result for the very first time. It will streamline sample reception significantly and will further reduce turnaround times.”
Related Links:
Queen Elizabeth Hospital in Birmingham
Roche
The University Hospitals Birmingham NHS Foundation Trust has opened an automated blood sciences laboratory at the new Queen Elizabeth Hospital in Birmingham (Birmingham, United Kingdom). Equipped with state-of-the-art Roche (Burgess Hill, United Kingdom) analytical platforms and track system, the new laboratory ensures a very efficient workflow and will reduce turnaround times (TAT) for routine, high throughput work.
The track system consists of two cobas 8000 platforms (one with two cobas c 701 chemistry modules and two cobas e 602 immunoassay modules and the other with one cobas c 701 and two cobas e 602 modules), a modular preanalytics module and a cobas p 501/701 post-analytical unit for automated sample storage and retrieval.
The cobas 8000 modular analyzer series is designed for high workload laboratories and can cover a range of 3 up to 15 million tests per year. With a peak throughput of 8,400 tests per hour and many innovative design elements to allow unrestricted sample flow and intelligent sample routing, the cobas 8000 modular analyzer series significantly improves sample turnaround time and efficiently addresses peak demands. High speed, intelligent sample dynamics, and workflow improvements further enhance productivity and efficiency for high workload laboratories.
“The fully automated track system with pre- and post-analytics has eliminated the need for manual transfer and storage of samples once they are loaded on the system”, explained laboratory manager, Chris Gaskin. “The cobas 8000 platforms are designed for high throughput and the whole Roche solution has helped us to be more lean in our processes and is much more TAT efficient for our high workloads.”
The laboratory also has a standalone cobas p 512 module for automated sample receipt. “In the next few months, we aim to introduce a pneumatic sample delivery system and ward order communications throughout the hospital,” Chris Gaskin concluded. “When a test is requested on the ward, a barcode label will be printed automatically. Then, when samples arrive in the laboratory, they will be loaded directly onto the cobas p 512. The system will register receipt on Laboratory Information Management System (LIMS) and then sort the samples into appropriate racks, depending on their destination. This will eliminate the need for paperwork, allowing the process to be entirely electronic from request to result for the very first time. It will streamline sample reception significantly and will further reduce turnaround times.”
Related Links:
Queen Elizabeth Hospital in Birmingham
Roche
Latest Technology News
- AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
- Agentic AI Platform Supports Genomic Decision-Making in Oncology
- Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance
- Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
- AI-Enabled Assistant Unifies Molecular Workflow Planning and Support
- AI Tool Automates Validation of Laboratory Software Configuration Changes
- Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
- Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
- Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
- New Platform Captures Extracellular Vesicles for Early Cancer Detection
- Microfluidic Single-Cell Assay Predicts Breast Cancer Risk
- AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer
- Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing
- Noninvasive Sputum Test Detects Early Lung Cancer
- New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
- Rapid Biosensor Detects Drug Sensitivity in Breast Tumors
Channels
Clinical Chemistry
view channel
Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features
Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more
Plasma Vitamin C Levels Associated with Brain Structure and Connectivity in Aging
Previous studies have linked vitamin C–rich diets with lower risk of cognitive impairment in older adults. However, few investigations have directly examined blood plasma vitamin C in relation to brain... Read more
Mass Spectrometry Detects Tumor Metabolites for Cancer Monitoring
Cancer’s altered metabolism complicates how clinicians detect and monitor tumors, because nutrient use can shift with context and time. Measuring small-molecule metabolites that distinguish malignant from... Read more
Urinary Biomarker Assay Predicts Kidney Disease Progression Beyond Standard Measures
Many patients with type 2 diabetes and chronic kidney disease continue to experience progressive renal decline, yet conventional markers such as albuminuria and estimated glomerular filtration rate (eGFR)... Read moreMolecular Diagnostics
view channel
Ultrasensitive HPV Blood Test Predicts Early Recurrence in Head and Neck Cancer
Human papillomavirus (HPV)-associated head and neck cancers are frequently treated with surgery, but some patients experience recurrence due to residual microscopic disease. Postoperative decisions about... Read more
New Library Normalization and Amplification Tools Support Oncology Sequencing
High-throughput next-generation sequencing (NGS) laboratories continue to grapple with uneven library pooling and amplification artifacts that can degrade variant calling accuracy and increase reruns.... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
TORCH Infection Trends Point to Need for Tailored Screening in Pregnancy
Congenital TORCH infections can be asymptomatic during pregnancy yet cause stillbirth, birth defects, and lifelong disability in infants. Many regions still lack robust surveillance to guide testing and... Read more
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read morePathology
view channel
Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer
Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
AI Tool Speeds Brain Tumor Classification from Routine Histology Slides
Accurate classification of brain and spinal cord tumors increasingly depends on molecular profiling alongside histology, but access to such testing remains limited and results can take about two weeks.... Read more
IHC Companion Diagnostic Standardizes Mismatch Repair Testing for Cancer Immunotherapy
Deficient DNA mismatch repair is an established predictive biomarker for response to immune checkpoint inhibitors, yet access to standardized assessment has varied across tumor types. Cancer remains the... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Open-Source Consortium Aims to Standardize Digital Pathology Workflows
Digital pathology is expanding rapidly as laboratories adopt whole-slide imaging and computational tools to meet growing diagnostic and biomarker-testing demand. However, fragmented software infrastructure... Read more








